This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          July 01, 2014

Home  |   About ASHI  |   Education  |   Publications  |   Meetings  |   Careers  |   News  |   Lab Center


 

Technologists: A forum just for you!
ASHI
On the ASHI website there is a forum for the exclusive use of our technologist members. This forum is created through LinkedIn and provides technologists with a place where they can share information and strategies, ask or answer questions, or network with their colleagues. Take advantage of this unique opportunity to learn and grow in the HLA field! To participate, look under the Education tab on the ASHI website, or go here.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Don't miss the 40th anniversary of ASHI!


Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Training opportunities available
ASHI
We would like to remind ASHI members that a database has been set up to list those laboratories which are willing to receive visiting scientists or technologists interested in learning specific laboratory techniques. There are currently 10 laboratories that volunteered to do this.

There is no cost for the training; participants would be responsible for covering their own travel expenses while visiting the host lab.

If you or someone in your lab would like to take advantage of this unique opportunity, contact ASHI headquarters at info@ashi-hla.org. Be sure to specify which technique you are interested in learning.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Let Career Center help you find qualified HLA employees
ASHI
Anyone in the field can tell you that finding qualified employees who are knowledgeable about HLA is not easy. Let ASHI help! For a very low cost companies can have their job openings posted on ASHI’s website in the Career Center, where hundreds of HLA-experienced potential employees will see it. To find out more, or have your job opening posted, go to the Career Center today.

And ASHI members – between jobs? Recently graduated? Check out the Career Center to see what’s available. You can also post your resume for free!

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


INDUSTRY NEWS


Microenvironment of hematopoietic stem cells can be a target for myeloproliferative disorders
Medical Xpress
The protective microenvironment of the hematopoietic stem cell niche, which produces cells of the blood and the immune system, also protects against myeloproliferative neoplasia. The discovery of a new therapeutic target for certain kinds of myeloproliferative disease is, without doubt, good news. This is precisely the discovery made by the Stem Cell Physiopathology group at the CNIC (the Spanish National Cardiovascular Research Center), led by Dr. Simón Méndez–Ferrer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Gene profiling could signal start of personalized medicine in rheumatoid arthritis
Oncology Practice Digital Network via The Oncology Report
A set of genetic polymorphisms is beginning to allow researchers to predict which patients with rheumatoid arthritis will have a severe disease course, as well as determine their response to treatment and risk of death. Changes in amino acids at positions 71 and 74 of the HLA-DRB1 gene, which are a part of the "shared epitope" that is already known to increase genetic susceptibility for rheumatoid arthritis, as well as a new polymorphism at position 11 of the HLA-DRB1 gene that is outside the shared epitope, are key to this effort.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Researchers develop T-cells to fight viral attacks in bone marrow transplant patients
Yotta Fire
Following a hematopoietic stem cell transplant, a patient is usually at a risk of fatal infections. However, scientists say they may have found an "effective and rapid" response to keep infections at bay. In a news release, Baylor College of Medicine said the method employs the T-cells or virus-specific immune cells. They identify viruses and kill infected tissues; patients who have had a bone marrow transplant lack these cells.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
 



ASHI Insights
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Lauren Swan, Content Editor, 202.684.7496  
Contribute news


Learn how to add us to your safe sender list so our emails get to your inbox.

This edition of ASHI Insights was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063